Watch: Study finds racial disparities in HIV medication use

Exterior of the Center for Disease Control (CDC) headquarters is seen on October 13, 2014 in Atlanta, Georgia. Frieden urged hospitals to watch for patients with Ebola symptoms who have traveled from the tree Ebola stricken African countries. (Photo by Jessica McGowan/Getty Images)

Advances in medicine have allowed the creation of highly effective HIV-prevention drugs. PrEP, for example, has a 99% prevention rate against the virus through contact. As good as the numbers sound, a study done by the Centers for Disease Control and Prevention found major usage disparities among those at risk. The study found that among the at-risk population, just 13 percent of Black people were using the medication compared with 94 percent of white patients and 15 percent of women. Dr. Bayo Curry-Winchell, an urgent care medical director, joined Marc Lamont Hill to talk about the lack of understanding and access to the drug.

Learn more about HIV Prep from the clip above, and tune into theGrio with Marc Lamont Hill tonight at 7 pm ET on theGrio cable channel.

Exit mobile version